SCHEMBL9684260

SCHEMBL9684260

CC(C)(C)[Si](C)(C)OCCN1C2c3ccccc3C1c1sccc12

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DUT P33316 2/20 0.33
EHMT2 Q96KQ7 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683453 0.73 OPRM1 (0.35)
SCHEMBL9683465 0.72 CARM1 (0.33)
SCHEMBL9684167 0.71 ALDH1A1 (0.31)
SCHEMBL9683338 0.70 POLB (0.34)
SCHEMBL9684281 0.66 OPRM1 (0.37)
SCHEMBL9682616 0.64 KDM1A (0.46)
SCHEMBL9682600 0.62 DUT (0.36) DUT
SCHEMBL25366880 0.62 CYP1A2 (0.42) DUT
SCHEMBL30528601 0.62 CYP1A2 (0.42) DUT
SCHEMBL9683323 0.61 HTT (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0475187-A1 Naphthothiophenimines for treating neuronal disorders caused by ischemia BRISTOL-MYERS SQUIBB COMPANY (US) 1992-03-18 EP disclosed
US-5064831-A N-methyl-d-aspartate receptor antagonist BRISTOL-MYERS SQUIBB CO. (US) 1991-11-12 US disclosed